Scynexis Inc
Nasdaq: SCYX
- Raised $11 million (2012)
- 18 clinical trials
- 1 FDA-registered drug site
- Research grants: $448,280
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Encore Medical, Inc.
- Raised $1.1 million (2022)
- 22 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2017
Eyenuk, Inc.
- Raised $5.6 million (2026)
- 4 clinical trials
- FDA-cleared or approved devices
- Research grants: $20 million
Zenflow, Inc.
- Raised $19 million (2024)
- 7 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $5.1 million
Click Therapeutics, Inc.
- Raised $49 million (2025)
- 17 clinical trials
- FDA-cleared or approved devices
- Research grants: $899,766
Brainsway Ltd.
Nasdaq: BWAY
- Raised $20 million (2024)
- 21 clinical trials, 1 active
- FDA-cleared or approved devices
Lumicell, Inc.
- Raised $198 million (2025)
- 11 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $5.6 million
MAIA Biotechnology, Inc.
NYSE: MAIA
- Raised $1.5 million (2026)
- 2 clinical trials, 2 active
- Research grants: $2.3 million
Transcode Therapeutics, Inc.
Nasdaq: RNAZ
- Raised $8 million (2024)
- 2 clinical trials, 1 active
- Research grants: $8.6 million
Hologic Inc
- Raised $450 million (2010)
- 28 clinical trials, 2 active
- FDA-cleared or approved devices
Shape Memory Medical Inc.
- Raised $17 million (2026)
- 8 clinical trials, 7 active
- FDA-cleared or approved devices
- Research grants: $4.8 million
Polarean, Inc.
- Raised $1.9 million (2015)
- 3 clinical trials
- FDA-cleared or approved devices
- 1 FDA-registered drug site
PROCEPT BioRobotics Corp
Nasdaq: PRCT
- Raised $85 million (2021)
- 13 clinical trials, 3 active
- FDA-cleared or approved devices
LENSAR, Inc.
Nasdaq: LNSR
- Raised $20 million (2023)
- 4 clinical trials
- FDA-cleared or approved devices
- Founded 2004
Lineage Cell Therapeutics, Inc.
NYSE: LCTX
- Raised $3.5 million (2014)
- 5 clinical trials, 3 active
- Research grants: $6.3 million
Mercator Medsystems Inc
- Raised $14 million (2019)
- 10 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $15 million
UroGen Pharma Ltd.
Nasdaq: URGN
- Raised $120 million (2023)
- 19 clinical trials, 4 active
- FDA-cleared or approved devices
Pfizer Inc
NYSE: PFE
- 3566 clinical trials, 249 active
- FDA-cleared or approved devices
- 7 FDA-registered drug sites
electroCore, Inc.
Nasdaq: ECOR
- Raised $1.9 million (2025)
- 20 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2018
RefleXion Medical, Inc.
- Raised $107 million (2023)
- 3 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $6.4 million
Showing 100 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences